SMis 3rd Annual Global Protein Summit (Global Protein Summi)

Venue: Lord’s Cricket Ground, London

Location: London, United Kingdom

Event Date/Time: Jun 06, 2007 End Date/Time: Jun 07, 2007
Report as Spam


With staggering growth rates, the booming Biopharmaceutical industry has been increasingly diverting resources to protein research.
Great contributions have been made through academic research but it is the pharmaceutical industry that solely faces unique challenges, in its strive to progress compounds into novel drugs:

- Targeting Expression and purification demands
- Optimizing Efficacy and activity levels
- Overcoming challenges in structural research for drug design

The SMi Group's 3rd Annual Global Protein Summit is designed to meet the needs of the industry. Bringing together Vice Presidents, Directors, Heads and leading Researchers from the pharmaceutical industry to share successes and discuss the critical issues surrounding the development of innovative protein drug compounds.

Hear contributions from leading industry experts, including:

- Dr Thomas Bumol, Vice President, Biotechnology Discovery Research and Applied Molecular Evolution, Eli Lilly
- Dr Niels C Kaarsholm, Corporate Vice President, Protein Engineering, Diabetes Research, Novo Nordisk
- Dr Robert Wynands, Director, Structural Biology, Takeda
- Dr Zhijian Lu, Assistant Director, Biotherapeutics Expression and Purification, Wyeth
- Dr Niek Dekker, Associate Director, Protein Engineering, Global Structural Chemistry, AstraZeneca
- Dr Cory R Brouwer, Associate Director, Knowledge Management Informatics, Pfizer
- Dr Bernardo Perez-Ramirez, Scientific Director, Bio-Formulations Development, Genzyme
- Dr Hans De Haard, Senior Director, Technology and Discovery, Ablynx
- Dr Charles H Squires, Senior Director, Biopharmaceutical Services, Dowpharma
- Dr Joey M Studts, Principal Scientist and Head, Protein Resources, Boehringer-Ingelheim
- Dr Stephen Irving, Senior Principal Scientist, Pfizer
- Dr Lukas Leder, Research Investigator, Protein Expression and Purification, Centre of Proteomic Chemistry, Novartis
- Dr Ramkrishna Sadhukhan, Bioresearch Centre, Abbott Laboratories

The SMi Group's 3rd Annual Global Protein Summit offers a unique opportunity to hear about the latest developments from world leaders.
Bringing together knowledge and expertise, it's designed to create the perfect setting for the exchange of ideas and networking opportunities.


Decreasing time to protein for Assay Development to Structural Research
5th June 2007, Central London, In Association with: Boehringer-Ingelheim